PD-1/PD-L1 resistance has been shown to be associated with PD-1/PD-L1 expression levels on the cell surface, the absence of first and co-stimulatory signals, the tumor microenvironment, and epigenetic modifications. This evidence concerns the gene CD274 and neoplasm.